Kroger installs Avery Weigh-Tronix Eyecon pharmacy automation machines
LIVONIA, Mich. — Kroger is installing Avery Weigh-Tronix’s tabletop pharmacy automation systems in its stores, Avery said.
The Eyecon is an automated prescription validation, counting and filling system that Avery said enhances inventory management by improving filling accuracy. The machine includes the Visual Counting System, using machine vision technology that increases counting and filling speed by up to 76% over manual counting and filling with a camera mounted above the counting tray that captures five images per second and counts pills within 200 milliseconds.
"Using the Eyecon to count solid-dosage form products saves us time," Kroger pharmacy project manager Mike Menkhaus said. "We noticed a difference, particularly for product audits and physical inventory counts, making the system a great investment."
Breast cancer drug may increase diabetes risk among older women
NEW YORK — A popular breast cancer treatment may pose an increased risk of diabetes among older women, according to a new study.
The research, which was published in the latest issue of Cancer, found that among more than 14,000 breast cancer survivors, ages 65 years and up, 10% were diagnosed with diabetes over a 5-year period. However, the likelihood of developing diabetes was 25% more among those taking breast cancer drug tamoxifen.
Despite the increased risk, the researchers did note that additional factors (i.e., obesity and family history) could influence the increased risk and that the results do not prove that tamoxifen directly causes the development of diabetes. Further investigation is needed to explore the association, the study authors concluded.
‘Good’ cholesterol levels could cut heart attack, stroke risk among diabetes patients
PORTLAND, Ore. — It seems that boosting high-density lipoproteins levels, also known as "good" cholesterol, can help diabetes patients reduce their risk of heart attack and stroke, according to a new study conducted by Kaiser Permanente published in the American Journal of Cardiology.
Examining the records of 30,067 patients with diabetes that entered Kaiser Permanente diabetes registries across Oregon, Washington and Georgia between 2001 and 2006, researchers noted that the patients had at least two HDL cholesterol measurements between six to 24 months apart. Following up eight years later, they found that patients with increased HDL levels (22% had increased levels during their initial measurements) had 8% fewer heart attacks and strokes, compared with those whose HDL levels remained the same. Similarly, those patients with decreased HDL levels experienced 11% more heart attacks and strokes.
Researchers noted that while many patients in the study were on statins to reduce their low-density lipoproteins levels (LDL levels), or "bad" cholesterol, few were on medications to boost HDL.
"Our study adds to the growing body of evidence that raising HDL levels may be an important strategy for reducing heart attack risk," said Gregory Nichols, lead study author and senior investigator with Kaiser Permanente Center for Health Research in Portland, Ore.